I am investigating cancer recurrence mechanisms using a cancer stem cell-based liquid
biopsy platform with CRISPR-Cas technology, as well as integrating in vivo and in vitro
models under the 3R framework at the transcriptomic level. Additionally, I leverage my
engineering background in the development and validation of medical devices and implants.